The diagnosis of brain death in ICU patients on ECMO by means of an apnea test requires the exclusion of neuropathy and myopathy
Journal of Biomedicine and Biosensors · 2025
DOI: 10.58613/jbb531 ↗At a glance
Journal article in Journal of Biomedicine and Biosensors, 2025. Written by Josef Finsterer and 2 co-authors.
Topics: Intensivpflege
Abstract (original language)
We were interested to read the article by Faria et al. on the diagnosis of brain death in intensive care patients undergoing extracorporeal membrane oxygenation(ECMO) using an apnea test [1]. The authors propose an apnea test based on a low-sweep flow protocol (200ml/minute) to achieve a CO2 partial pressure of >55mmHg, which corresponds to brain death. In cases of severe hypoxemia during the test, it was proposed to increase ECMO blood flow to maintain oxygenation [1]. The authors concluded that their physiologically based proposal represents a clinically feasible strategy for managing the complex interplay between gas exchange, oxygenation and CO2 clearance during the apnea test [1]. The study is noteworthy, but some points should be discussed.
Cite
APA
Finsterer, J., Scorza, F., & Scorza, C. (2025). The diagnosis of brain death in ICU patients on ECMO by means of an apnea test requires the exclusion of neuropathy and myopathy. Journal of Biomedicine and Biosensors. https://doi.org/10.58613/jbb531
Vancouver
Finsterer J, Scorza F, Scorza C. The diagnosis of brain death in ICU patients on ECMO by means of an apnea test requires the exclusion of neuropathy and myopathy. Journal of Biomedicine and Biosensors. 2025. doi:10.58613/jbb531
BibTeX
@article{Finsterer2025,
author = {Finsterer, Josef and Scorza, FA and Scorza, CA},
title = {The diagnosis of brain death in ICU patients on ECMO by means of an apnea test requires the exclusion of neuropathy and myopathy},
journal = {Journal of Biomedicine and Biosensors},
year = {2025},
doi = {10.58613/jbb531}
}
EUVIMED